Sugi Predict

Sugi Predict / Compounds / SCHEMBL179812

SCHEMBL179812

SCHEMBL179812

CC[C@](N)(CCC(=O)O)C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 1.00
▸ MEN1 O00255 2/20 1.00
▸ KMT2A Q03164 2/20 1.00
▸ CYP1A2 P05177 1/20 1.00
▸ THRB P10828 1/20 1.00
▸ ARG1 P05089 1/20 0.53
▸ ARG2 P78540 1/20 0.53
▸ NAALAD2 Q9Y3Q0 1/20 0.41
▸ FFAR3 O14843 1/20 0.40
▸ HDAC3 O15379 1/20 0.40
▸ HDAC1 Q13547 1/20 0.40
▸ HDAC2 Q92769 1/20 0.40
▸ HDAC8 Q9BY41 1/20 0.40
▸ NOS3 P29474 1/20 0.39
▸ NOS1 P29475 1/20 0.39
▸ NOS2 P35228 1/20 0.39
▸ ODC1 P11926 1/20 0.36
▸ AKR1B1 P15121 1/20 0.36
▸ LMNA P02545 1/20 0.35
▸ ALKBH5 Q6P6C2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5485081 1.00 ALDH1A1 (1.00) ALDH1A1MEN1KMT2ACYP1A2THRB
SCHEMBL1308931 1.00 ALDH1A1 (1.00) ALDH1A1MEN1KMT2ACYP1A2THRB
SCHEMBL1300539 0.87 ALDH1A1 (0.77) ALDH1A1MEN1KMT2ACYP1A2THRB
SCHEMBL9586044 0.85 CYP1A2 (0.74) ALDH1A1MEN1KMT2ACYP1A2THRB
SCHEMBL7086649 0.84 ALDH1A1 (0.73) ALDH1A1MEN1KMT2ACYP1A2THRB
SCHEMBL1399007 0.84 ALDH1A1 (0.73) ALDH1A1MEN1KMT2ACYP1A2THRB
SCHEMBL9005565 0.84 ALDH1A1 (0.73) ALDH1A1MEN1KMT2ACYP1A2THRB
SCHEMBL24163861 0.81 MEN1 (0.68) ALDH1A1MEN1KMT2ACYP1A2THRB
SCHEMBL6759254 0.81 MEN1 (0.68) ALDH1A1MEN1KMT2ACYP1A2THRB
SCHEMBL6759253 0.81 MEN1 (0.68) ALDH1A1MEN1KMT2ACYP1A2THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240240152-A1 Protection of Beta Cells from Immune Attack JOSLIN DIABETES CENTER (US) 2024-07-18 — — US claimed
WO-2023125112-A1 ANTAGONIST COMPOSITION AND APPLICATION THEREOF IN PREPARATION OF DRUG FOR TREATMENT OF SLEEP DISORDERS WITH CO-MORBID PSYCHIATRIC DISORDERS 中国科学院深圳先进技术研究院 2023-07-06 — — WO claimed
EP-4052271-A1 MODULAR AUTOMATED PHYSICAL HEALTH TESTING SYSTEMS AND ASSOCIATED DEVICES AND METHODS Reperio Health, Inc. (US) 2022-09-07 — — EP claimed
CN-114902347-A Modular automated physical fitness testing system and associated apparatus and method 雷佩里奥健康公司 2022-08-12 — — CN claimed
CN-114225039-A Antagonist composition and application thereof in preparation of medicine for treating sleep disorder and mental disease 中国科学院深圳先进技术研究院 2022-03-25 — — CN claimed
EP-3160464-A1 USE OF BUSPIRONE METABOLITES Contera Pharma APS (DK) 2017-05-03 — — EP claimed
WO-2015197079-A1 USE OF BUSPIRONE METABOLITES CONTERA PHARMA APS (DK) 2015-12-30 — — WO claimed
US-20080187492-A1 Drosophila Models For Diseases Affecting Learning and Memory NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR 2008-08-07 — — US claimed
WO-2005104836-A2 DROSOPHILA MODELS FOR DISEASES AFFECTING LEARNING AND MEMORY ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) 2005-11-10 — — WO claimed
EP-1282680-A1 COMPOSITIONS COMPRISING CYCLODEXTRIN THE PROCTER & GAMBLE COMPANY (US) 2003-02-12 — — EP claimed
US-6503413-B2 Polyalkylene polysiloxane, buffering agent, aqueous carrier THE PROCTER & GAMBLE COMPANY 2003-01-07 — — US claimed
EP-1255806-A1 STABLE, AQUEOUS COMPOSITIONS FOR TREATING SURFACES, ESPECIALLY FABRICS THE PROCTER & GAMBLE COMPANY (US) 2002-11-13 — — EP claimed
US-20020011584-A1 Stable, aqueous compositions for treating surfaces, especially fabrics THE PROCTOR & GAMBLE COMPANY 2002-01-31 — — US claimed
US-20020010154-A1 Compositions comprising cyclodextrin THE PROCTER & GAMBLE COMPANY 2002-01-24 — — US claimed
WO-2001088076-A1 COMPOSITIONS COMPRISING CYCLODEXTRIN THE PROCTER & GAMBLE COMPANY (US) 2001-11-22 — — WO claimed
WO-2001060961-A1 STABLE, AQUEOUS COMPOSITIONS FOR TREATING SURFACES, ESPECIALLY FABRICS THE PROCTER & GAMBLE COMPANY (US) 2001-08-23 — — WO claimed
US-12635917-B2 Remote blood volume monitor DAXOR CORP. (US) 2026-05-26 — — US disclosed
US-12633401-B2 Modular automated physical health testing systems and associated devices and methods Reperio Health, Inc. (US) 2026-05-19 — — US disclosed
EP-0073143-A2 Novel complex amido and imido derivatives of carboxyalkyl peptides and thioethers and ethers of peptides Ryan, James Walter (US) 1983-03-02 — — EP disclosed
EP-0048159-A2 Novel carboxyalkyl peptides and thioethers and ethers of peptides as antihypertensive agents UNIVERSITY OF MIAMI (US) 1982-03-24 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020010154-A1 Compositions comprising cyclodextrin FFAR4, FRG1, FGB ALDH1A1 3053/4885MEN1 4077/4885KMT2A 4191/4885
US-12633401-B2 Modular automated physical health testing systems and associated devices and methods USP36, TRIB2, TRIB1 ALDH1A1 1874/4885MEN1 593/4885KMT2A 1735/4885
US-12635917-B2 Remote blood volume monitor HBG2, HBB, HBG1 ALDH1A1 2976/4885MEN1 1052/4885KMT2A 1669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.